By inhibiting NNMT, 5-Amino-1MQ essentially removes a metabolic brake, allowing the body to burn fat more efficiently and maintain healthier NAD+ levels
One aspect of the invention pertains to the administration of one or more NNMT inhibitors by, for example, contacting one or more cells of an animal to: muscular disorders including, but not limited to, sarcopenia, muscle atrophy, Duchenne muscular dystrophy, Becker muscular dystrophy, Limb-girdle muscular dystrophies, Pompe disease, cardiac myopathies, pulmonary disorders
Product Name: 5-Amino-1MQ Strength: 10mg Chemical Name: 5-Amino-1-methylquinolinium CAS Number: 685079-15-6 Molecular Formula: CHN Molecular Weight: 159.21 g/mol Appearance: YellowOrange Crystalline Solid Classification: Small-Molecule NNMT Inhibitor Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Metabolic & weight research Store lyophilized material refrigerated at 28C for routine storage
Summary: Feeling worse after a B12 injection typically reflects your body adjusting to replenished vitamin levels, triggering metabolic processes that may temporarily cause fatigue, headaches, or injection site discomfort
